Associated Papers
BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapy.
Pattalachinti VK et al.
Npj Precision Oncology, 2025
39910160 (PubMed )
Supplement: 41698_2025_821_MOESM1_ESM.pdf
Negative reactions of BRAF mutation-specific immunohistochemistry to non-V600E mutations of BRAF.
Seto K et al.
Pathology International, 2020
Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ et al.
Oncotarget, 2015
25980437 (PubMed )
Supplement: oncotarget-06-18066-s004.xlsx › Sheet1
Select a paper to view details